Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metastatic squamous and nonsquamous non-small cell lung cancer (NSCLC).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04205812
Study type Interventional
Source Incyte Corporation
Contact
Status Active, not recruiting
Phase Phase 3
Start date September 11, 2020
Completion date April 15, 2025

See also
  Status Clinical Trial Phase
Withdrawn NCT02941601 - A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) Phase 2
Terminated NCT02564380 - Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC) Phase 2